Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
企業コードAMIX
会社名Autonomix Medical Inc
上場日Jan 29, 2024
最高経営責任者「CEO」Mr. Bradley (Brad) Hauser
従業員数8
証券種類Ordinary Share
決算期末Jan 29
本社所在地21 Waterway Ave, Suite 300
都市THE WOODLANDS
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号77380
電話番号18322777816
ウェブサイトhttps://autonomix.com/
企業コードAMIX
上場日Jan 29, 2024
最高経営責任者「CEO」Mr. Bradley (Brad) Hauser
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし